Item request has been placed!
×
Item request cannot be made.
×

Processing Request
Broad spectrum immunomodulatory effects of Anopheles gambiae microRNAs and their use for transgenic suppression of Plasmodium.
Item request has been placed!
×
Item request cannot be made.
×

Processing Request
- Additional Information
- Source:
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE
- Publication Information:
Original Publication: San Francisco, CA : Public Library of Science, c2005-
- Subject Terms:
- Abstract:
Malaria, caused by the protozoan parasite Plasmodium and transmitted by Anopheles mosquitoes, represents a major threat to human health. Plasmodium's infection cycle in the Anopheles vector is critical for transmission of the parasite between humans. The midgut-stage bottleneck of infection is largely imposed by the mosquito's innate immune system. microRNAs (miRNAs, small noncoding RNAs that bind to target RNAs to regulate gene expression) are also involved in regulating immunity and the anti-Plasmodium defense in mosquitoes. Here, we characterized the mosquito's miRNA responses to Plasmodium infection using an improved crosslinking and immunoprecipitation (CLIP) method, termed covalent ligation of endogenous Argonaute-bound RNAs (CLEAR)-CLIP. Three candidate miRNAs' influence on P. falciparum infection and midgut microbiota was studied through transgenically expressed miRNA sponges (miR-SPs) in midgut and fat body tissues. MiR-SPs mediated conditional depletion of aga-miR-14 or aga-miR-305, but not aga-miR-8, increased mosquito resistance to both P. falciparum and P. berghei infection, and enhanced the mosquitoes' antibacterial defenses. Transcriptome analysis revealed that depletion of aga-miR-14 or aga-miR-305 resulted in an increased expression of multiple immunity-related and anti-Plasmodium genes in mosquito midguts. The overall fitness cost of conditionally expressed miR-SPs was low, with only one of eight fitness parameters being adversely affected. Taken together, our results demonstrate that targeting mosquito miRNA by conditional expression of miR-SPs may have potential for the development of malaria control through genetically engineered mosquitoes.
- Abstract:
The authors have declared that no competing interests exist.
- References:
Nat Commun. 2015 Nov 25;6:8864. (PMID: 26602609)
Cell. 2013 Apr 25;153(3):654-65. (PMID: 23622248)
Mol Cells. 2016 May 31;39(5):375-81. (PMID: 27117456)
Dev Comp Immunol. 2015 Mar;49(1):170-8. (PMID: 25445902)
Curr Biol. 2003 Apr 29;13(9):790-5. (PMID: 12725740)
J Innate Immun. 2014;6(2):169-81. (PMID: 23988482)
Am J Trop Med Hyg. 2007 Jun;76(6):1118-24. (PMID: 17556621)
Nat Rev Genet. 2011 Feb;12(2):99-110. (PMID: 21245828)
Genes Dev. 2014 Nov 1;28(21):2421-31. (PMID: 25367037)
Science. 2011 May 13;332(6031):855-8. (PMID: 21566196)
Pathog Glob Health. 2017 Dec;111(8):424-435. (PMID: 29385893)
PLoS Pathog. 2009 Sep;5(9):e1000576. (PMID: 19750215)
Nat Rev Genet. 2015 Jul;16(7):421-33. (PMID: 26077373)
Rev Inst Med Trop Sao Paulo. 2012 Sep-Oct;54(5):287-92. (PMID: 22983293)
Proc Natl Acad Sci U S A. 2017 Mar 7;114(10):E1895-E1903. (PMID: 28223504)
Insect Biochem Mol Biol. 2009 Dec;39(12):903-12. (PMID: 19883761)
PLoS Negl Trop Dis. 2018 May 2;12(5):e0006463. (PMID: 29718912)
PLoS Pathog. 2018 Mar 8;14(3):e1006898. (PMID: 29518156)
Nucleic Acids Res. 2007;35(20):6953-62. (PMID: 17933784)
Trends Parasitol. 2018 Jul;34(7):603-616. (PMID: 29793806)
Nature. 2009 Jul 23;460(7254):479-86. (PMID: 19536157)
Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11508-13. (PMID: 9326640)
BMC Genomics. 2014 Jul 04;15:557. (PMID: 24997592)
Cell. 2004 Mar 5;116(5):661-70. (PMID: 15006349)
PLoS Pathog. 2011 Dec;7(12):e1002458. (PMID: 22216006)
Trends Parasitol. 2006 May;22(5):197-202. (PMID: 16564223)
Biology (Basel). 2012 Dec 14;1(3):895-905. (PMID: 24832523)
Malar J. 2013 Apr 26;12:142. (PMID: 23622561)
Sci Rep. 2017 Jul 26;7(1):6493. (PMID: 28747726)
Proc Natl Acad Sci U S A. 2015 Dec 8;112(49):E6736-43. (PMID: 26598698)
Proc Natl Acad Sci U S A. 2016 Aug 16;113(33):E4828-36. (PMID: 27489347)
G3 (Bethesda). 2018 Jan 4;8(1):185-193. (PMID: 29146584)
Nat Struct Mol Biol. 2012 Feb 12;19(3):321-7. (PMID: 22343717)
Proc Natl Acad Sci U S A. 2015 Feb 3;112(5):1440-5. (PMID: 25605933)
Nat Methods. 2009 Dec;6(12):897-903. (PMID: 19915559)
Mem Inst Oswaldo Cruz. 2014 Aug;109(5):644-61. (PMID: 25185005)
Nat Biotechnol. 2018 Dec;36(11):1062-1066. (PMID: 30247490)
Mol Cell. 2014 Jun 19;54(6):1042-1054. (PMID: 24857550)
G3 (Bethesda). 2015 Apr 13;5(6):1151-63. (PMID: 25869647)
Nature. 2003 Sep 25;425(6956):415-9. (PMID: 14508493)
BMC Genomics. 2009 Dec 04;10:581. (PMID: 19961592)
Sci Rep. 2016 Nov 18;6:36625. (PMID: 27857164)
PLoS Pathog. 2012;8(8):e1002884. (PMID: 22927820)
Parasite Immunol. 2017 Feb;39(2):. (PMID: 28299810)
Nat Protoc. 2014 Mar;9(3):711-28. (PMID: 24577361)
Cell Microbiol. 2002 Nov;4(11):713-24. (PMID: 12427094)
Nat Struct Mol Biol. 2010 Feb;17(2):173-9. (PMID: 20062054)
PLoS Pathog. 2006 Jun;2(6):e52. (PMID: 16789837)
Science. 2017 Sep 29;357(6358):1396-1399. (PMID: 28963254)
Nat Methods. 2007 Sep;4(9):721-6. (PMID: 17694064)
J Mol Biol. 1990 Oct 5;215(3):403-10. (PMID: 2231712)
- Grant Information:
R01 AI122743 United States AI NIAID NIH HHS; R21 AI113989 United States AI NIAID NIH HHS
- Accession Number:
0 (MicroRNAs)
- Publication Date:
Date Created: 20200425 Date Completed: 20200727 Latest Revision: 20210724
- Publication Date:
20260130
- Accession Number:
PMC7202664
- Accession Number:
10.1371/journal.ppat.1008453
- Accession Number:
32330198
No Comments.